Skip to main content
. 2021 Jun 5;26(8):e1406–e1417. doi: 10.1002/onco.13841

Table 4.

Quality assessment of breast cancer costing studies

Percentage of maximum score Study design Cost + effect estimation Analysis + interpretation Total
≤50% 0 (0) 5 (15) 5 (15) 0 (0)
50%–70% 0 (0) 7 (21) 12 (36) 9 (27)
≥70% 33 (100) 21 (64) 16 (48) 24 (73)

Data are presented as n (%).

Data from the 33 studies that estimate the cost of multiple steps in the breast cancer care pathway.

Quality assessment based on Drummond checklist used; studies scored based on applicable categories [30].